Caris Close-Up

---

Caris AP Business Joins Miraca Holdings

Caris Life Sciences’ anatomic pathology business and its subsidiaries and affiliates (operated by Caris Diagnostics, Inc.) is now officially part of Miraca Holdings, Inc. Read more.

More about Miraca Holdings.

Meet the Caris Diagnostics Management Team.

---

Caris Life Sciences

Caris Life Sciences was founded because of an idea — that more precise and personalized health information can improve patients’ lives and ultimately improve healthcare for everyone. This drives everything we do, from developing a dynamic new cancer blood test for prostate cancer and other complex diseases, to diagnosing thousands of patients each day, to providing evidence-based, customized chemotherapy treatment guidance for oncologists and their cancer patients. We offer molecular pathology and tumor profiling, cancer blood tests and pathology lab services, across the continuum of care — diagnosis, prognosis and theranosis.

Our efforts are focused on diagnostics, prognostics and theranostics in three primary technology areas: Carisome^™ Circulating Microvesicle Technology, CarisPath^™ Expert Pathology Services and Caris Target Now^™ Molecular Pathology, Tumor Profiling and Evidence-Based Therapeutic Guidance.

• CarisPath provides expert pathology lab services for dermatology, gastroenterology, hematology and urology.
• Caris Target Now provides molecular pathology and tumor profiling service, coupled with evidence-based therapeutic guidance for cancer patients facing therapeutic uncertainty.
• Carisome Microvesicle Technology represents a revolution in blood-based diagnostic technologies. The technology is showing great potential for early detection and diagnosis of various cancers, as well as other complex diseases.

Caris employs a talented team of leading pathologists, histologists, molecular geneticists, molecular pathology experts, pathology lab technicians and other medical professionals. Our commitment to scientific excellence drives our hiring decisions and informs everything we do.

Subspecialty Expertise

Dermatology

Caris Life Sciences is dedicated to precision, collaboration and pathology lab excellence in a variety of diagnostic and prognostic dermatopathology services for various skin disorders.

Gastroenterology

Caris Life Sciences holds a strong leadership position in GI pathology, diagnosing thousands of patients daily with conditions ranging from gastritis to cancer.

Hematology

Caris provides next-generation, personalized hematopathology services, including advanced molecular pathology and blood pathology lab services.

Urology

Caris' urology experts utilize emerging science to ensure physicians and patients have access to the most informative, relevant diagnostic and prognostic information through our urologic pathology services.

Oncology

With proven anatomic and molecular pathology expertise, Caris helps physicians and their patients make more informed decisions about which treatments are likely to be most effective for cancer patients facing therapeutic uncertainty through our Caris Target Now Evidence-Based Molecular Profiling Service.